Research Article
Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis
Table 1
Characteristics of patients.
| ||||||||||||||||||||||||||||||
CCB, Ca2+ channel blockers; RAS, renin-angiotensin system; EPO, erythropoietin. |
| ||||||||||||||||||||||||||||||
CCB, Ca2+ channel blockers; RAS, renin-angiotensin system; EPO, erythropoietin. |